blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1957491

EP1957491 - PYRROLO (2,3-B) PYRIDINE DERIVATIVES USEFUL AS TEC KINASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.09.2010
Database last updated on 02.11.2024
Most recent event   Tooltip03.09.2010Application deemed to be withdrawnpublished on 06.10.2010  [2010/40]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
[2008/34]
Inventor(s)01 / BENTZIEN, Joerg, Martin
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road P.O. Box 368
Ridgefield, CT 06877-0368 / US
02 / TAKAHASHI, Hidenori
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road P.O. Box 368
Ridgefield, CT 06877-0368 / US
 [2008/34]
Representative(s)Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2008/34]Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date06837092.307.11.2006
[2008/34]
WO2006US43386
Priority number, dateUS20050735471P12.11.2005         Original published format: US 735471 P
[2008/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007058832
Date:24.05.2007
Language:EN
[2007/21]
Type: A2 Application without search report 
No.:EP1957491
Date:20.08.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 24.05.2007 takes the place of the publication of the European patent application.
[2008/34]
Search report(s)International search report - published on:EP19.06.2008
ClassificationIPC:C07D471/04, A61K31/437, A61P29/00, A61P37/00
[2008/34]
CPC:
C07D471/04 (EP,US); A61P1/04 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P25/00 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/34]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:PYROLLO PYRIDINE DERIVATIVE NUTZLICH ALS TEC-KINASE-INHIBITOREN[2008/34]
English:PYRROLO (2,3-B) PYRIDINE DERIVATIVES USEFUL AS TEC KINASE INHIBITORS[2008/34]
French:DERIVES DE PYRROLO (2,3-B) PYRIDINE UTILES COMME INHIBITEURS DE TEC KINASE[2008/34]
Entry into regional phase12.06.2008National basic fee paid 
19.12.2008Designation fee(s) paid 
19.12.2008Examination fee paid 
Examination procedure19.12.2008Examination requested  [2009/07]
25.03.2009Despatch of a communication from the examining division (Time limit: M04)
08.07.2009Reply to a communication from the examining division
26.10.2009Communication of intention to grant the patent
06.02.2010Application deemed to be withdrawn, date of legal effect  [2010/40]
23.04.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/40]
Fees paidRenewal fee
01.12.2008Renewal fee patent year 03
30.11.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO03041708  (BOEHRINGER INGELHEIM PHARMA [US]) [AD] 1-7 * the whole document *;
 [AD]WO2004016610  (ASTRAZENECA AB [SE], et al) [AD] 1-7* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.